| - SMTL ID
- 5shn.1
- Ligands
- ZINC ION; MAGNESIUM ION; ~{N}4-(4,5-dihydro-1,3-oxazol-2-ylmethyl)-2-methyl-~{N}3-(2-phenyl-3~{H}-imidazo[1,2-a]pyrimidin-7-yl)-1,5-dihydropyrazole-3,4-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5shn.2
- Ligands
- ZINC ION; MAGNESIUM ION; ~{N}4-(4,5-dihydro-1,3-oxazol-2-ylmethyl)-2-methyl-~{N}3-(2-phenyl-3~{H}-imidazo[1,2-a]pyrimidin-7-yl)-1,5-dihydropyrazole-3,4-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5shn.3
- Ligands
- ZINC ION; MAGNESIUM ION; ~{N}4-(4,5-dihydro-1,3-oxazol-2-ylmethyl)-2-methyl-~{N}3-(2-phenyl-3~{H}-imidazo[1,2-a]pyrimidin-7-yl)-1,5-dihydropyrazole-3,4-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5shn.4
- Ligands
- ZINC ION; MAGNESIUM ION; ~{N}4-(4,5-dihydro-1,3-oxazol-2-ylmethyl)-2-methyl-~{N}3-(2-phenyl-3~{H}-imidazo[1,2-a]pyrimidin-7-yl)-1,5-dihydropyrazole-3,4-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|